1 Except in the scarlet fever patients, some of whom were followed only 3 weeks. obtained by others for the purpose of convenient reference.
I. ANTISTREPTOLYSIN TITER IN NORMAL SUBJECTS
An analysis was made of the sera of 39 normal persons consisting of medical students and physicians. These subjects were free from any upper respiratory infection or other illness for a minimum of 4 weeks prior to examination. The titer was 25 units or less in 21, 50 units in 12, 100 units in 5, and 150 units in 1 person. Table I summarizes these results and those of other investigators. The median titer reported by most workers is 100 units or less. Myers and Keefer found the average (not median) titer to be 213 units. They used sheep erythrocytes instead of the customary rabbit cells, however, and von Hellens (3) had observed that sheep cells were more resistant to hemolysis by streptolysin than rabbit erythrocytes.
In view of our results we have considered 100 units per cc. of serum as the upper limit of normal. However, a rise in titer in serial tests, even though not exceeding 100 units, suggests hemolytic streptococcus infection, as is shown below in tests performed on patients with scarlet fever.
II. ANTISTREPTOLYSIN TITER IN SCARLET FEVER
In 1934 we studied 21 cases of scarlet fever admitted to Willard Parker Hospital during the months of January and February of that year. Blood was collected from each patient on the day of admission and again upon discharge.2 As will be seen from Table II, all patients except 1 had a normal antistreptolysin titer on admission. All but 4 showed an elevation of antistreptolysin titer during the course of the disease, although only 10 2The authors are indebted to Dr. Jesse M. Bullowa and Dr. I. H. Scheffer for permission to obtain these sera. Non-hemolytic streptococcus carriers Zuger (18 We have studied 171 adults with active rheumatic fever and 139 with inactive rheumatic heart disease. The patients were under observation on the wards and in the clinics for a period ranging from 4 weeks to several years. The criteria for activity were: (1) history of palpitation, precordial pain, fever, joint pains, or undue weight loss; (2) fever, tachycardia, gallop, changing murmurs or rhythm, pericardial friction rub, rheumatic skin manifestations, or subcutaneous nodules; (3) significant electrocardiographic changes; (4) elevated erythrocyte sedimentation rate or leukocytosis.
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In Table IV Sixty-seven per cent of the patients with or -without a preceding upper respiratory infection showed an antistreptolysin titer above 100 units. 5 The results with patients having chorea are comparable to the incidence of elevated titers in the group of patients with active rheumatic carditis and polyarthritis discussed above.
Twenty patients were treated with fever therapy, the hyperpyrexia being induced either by repeated typhoid vaccine injections or by means of the hypertherm. As has been previously noted by Todd (4) and by Coburn and Pauli (5), typhoid vaccine injections appeared to have no influence on the antistreptolysin titer. Similarly, fever induced by the hypertherm seemed to have no effect on the titer.
We could find no strict correlation between the 'We are grateful to Dr. Charles H. Smith and to the late Dr. Lucy P. Sutton for permitting us to study 18 cases from the Children's Medical Service of Bellevue Hospital. 5 Longcope (8) reports that of 8 cases of chorea, 7 showed a level above 100 units.
age of the patient, the severity of the chorea, and the height of antistreptolysin titer.
IV. ANTISTREPTOLYSIN TITER IN ARTHRITIS
A. Rheumatoid arthritis Blair and Hallman (9) found that of 45 patients with rheumatoid arthritis, 15 showed a high antistreptolysin titer. Longcope (8) observed that the antibody level was raised in 25 of 55 cases. Dawson and Olmstead (11) studied 219 cases and concluded that in the great majority of those whose illness was of long duration the titer was within normal limits, whereas in the cases of recent and particularly of acute onset, a significant number showed an abnormal titer.
We determined both the agglutinin titer and antistreptolysin titer of 205 sera from 72 patients with rheumatoid arthritis. The same strain of hemolytic streptococcus was used as an antigen for testing the content of both antibodies.6 Record was made of any history of a preceding upper respiratory infection and the duration of the disease. As will be seen from Table V, 85 per cent of the patients showed a normal titer and the median was 50 units. Of the 13 patients who had suffered with this condition for less than one year, 9 or 69 per cent gave normal titers; of the remaining 4 with titers above 100 units, 3 reported a recent upper respiratory infection. Of the 11 patients in the entire series with elevated antistreptolysin values, 36 per cent gave a history of recent respiratory infection, whereas only 10 per cent of patients with normal titers presented such a history. Thus, in most of our cases of rheumatoid arthritis, the antistreptolysin titer was within normal limits regardless of the stage of the disease or the severity of clinical symptoms. We found no correlation between the antistreptolysin and the hemolytic streptococcus agglutinin titers; three-quarters of the patients with high agglutinin titers (1:80 to 1:640) had a normal antistreptolysin titer.
B. Other types of arthritis Antistreptolysin determinations were made in 9 types of arthritis besides rheumatic fever and 6 We used N. Y. 5 as the antigen for the agglutinin titer and WPRL for the production of streptolysin. We subsequently learned that these two labels refer to the same strain. Where more than one determination was done in a given case, only the maximum titer was considered.
t In 9 of the 72 cases the exact duration of the illness was not determined. Of these the titer was 25 units in 3, 50 units in 3, 100 units in 2 and 150 units in 1. rheumatoid arthritis. The criteria for classifying these types have been described elsewhere (12) . The bases for differentiation were purposely made very strict and all cases about which we had any doubt were listed in one of the two " unclassified " categories. The results are presented in Table  VI . We studied 493 serum specimens of 320 patients. Eighty-five per cent of the entire group Acute pericarditis, with or without effusion, is associated, in most instances, with rheumatic fever or tuberculosis. Clinically, the differential diagnosis in some cases may be very difficult. We have observed 7 cases of acute pericarditis. In 6, this condition developed in the course of rheumatic fever, and every patient showed a titer above 100 (400, 300, 200, 150, 150) . The titer in the 1 case of tuberculous origin was 50 units.
Lupus erythemnatosus disserninatus and periarteritis nodosumn. Because of the similarities between some features of these two diseases and rheumatic fever, it was considered of interest to make antistreptolysin determinations in them. Two patients with each disease (confirmed at necropsy in each instance) were followed with serial bleedings over many months up to the time of death. The antistreptolysin titers were well within normal limits at all times. DISCUSSION A new serologic test such as the antistreptolysin titration is of interest to the clinician chiefly from two points of view: (1) the information it may give as to the etiology of certain diseases, and (2) its possible usefulness as a prognostic and diagnostic aid.
All investigators here cited, with the exception of Wilson and her associates, have found an elevated antistreptolysin titer in more than 80 per cent of patients with rheumatic fever. Both Coburn and Todd concluded from this that patients with rheumatic fever are responding immunologically to a hemolytic streptococcus infection. Wilson, Wheeler and Leask (6), on the other hand, believed that in their rheumatic patients "the rise of the level of antistreptolysin in the serum following respiratory infections seemed directly related to the extent of the local and constitutional symptoms irrespective of the presence of hemolytic streptococcus in the pharyngeal flora." They reported also that only one-third of their patients with active rheumatic fever who did not have respiratory infections exhibited a rise in antistreptolysin titer and that the titer of active rheumatic subjects experiencing respiratory infections was similar to that of inactive rheumatic subjects with these infections.
Our results do not bear out these findings of Wilson and her associates, although the antistreptolysin titers did tend to be higher in patients who developed rheumatic fever after distinct respiratory infections than in those whose rheumatic attacks were not preceded by such infections. Whether our patients who gave no history of respiratory infections actually had none, we cannot be certain, since we saw them, in most instances, only after the onset of rheumatic symptoms, but it can be said that these patients did not have respiratory infections of sufficient severity to be remembered by them. Our findings are largely in accord with those of Coburn and Pauli (5) although not in agreement with their report (13) that the onset of rheumatic fever coincided with a sharp rise in antistreptolysin titer. Indeed, many of our patients showed no rise until weeks after the onset of rheumatic fever and in a fair number the titer did not rise at all during periods of observation as long as 6 months. In this connection, however, it must be emphasized that some patients with such known hemolytic streptococcal diseases as scarlet fever and erysipelas show no antistreptolysin increase; so that the negative find-ings in some rheumatic patients are of little weight in arguing against the hemolytic streptococcal theory of etiology of that disease.
Since it has repeatedly been shown that a rise in the antistreptolysin level occurs only after infection with hemolytic streptococci and not after infection with other micro-organisms, our results, we believe, are in support of the view that there is an important relationship between rheumatic fever and hemolytic streptococcal infection. Whether the latter acts in a primary or merely in a contributory capacity, however, cannot be stated with such confidence.
In view of the lack of parallelism between the height of antistreptolysin titer and the severity of rheumatic fever, as mentioned previously, the test would appear to have little value in prognosis. As an aid in the differential diagnosis of rheumatic fever, the antistreptolysin test obviously must be interpreted with caution since it is in no way specific for that disease but merely indicates a present or recent infection with hemolytic streptococci. Nevertheless, the antistreptolysin titer is so constantly increased in rheumatic fever and so generally normal in other diseases involving the joints, that we have found the procedure distinctly useful as a confirmatory test, particularly in clinically atypical cases. Whether or not measurement of the antistreptolysin titer may be helpful in deciding whether the infectious process is active or inactive in rheumatic patients is not certain. Here again the test gives no specific indication of rheumatic activity but it does afford one more bit of presumptive evidence to be interpreted in the light of the clinical and other laboratory findings. 2. In normal individuals we have found the median titer to be 25 units and the normal maximum titer to be 100 units per cc.
3. Eighty per cent of patients with scarlet fever showed a rise in antistreptolysin titer during the course of the disease, but in only 48 per cent did it rise above 100 units in the 3-to 4-week period of observation.
4. The majority of all patients with active rheumatic fever showed a high antistreptolysin titer.
The incidence of elevated titers bore no relation to the various clinical manifestations of the rheumatic infection. Those patients whose illness was preceded by an upper respiratory infection sufficiently severe to be remembered, showed this immunological response more commonly than those without a history of preceding upper respiratory infection. Patients with inactive rheumatic heart disease usually had normal titers.
5. The majority of patients with chorea showed an increased titer regardless of whether or not the condition was associated with heart disease or polyarthritis. Age, severity of illness, and fever therapy did not seem to influence the antibody titer.
6. Patients with rheumatoid arthritis, as a rule, did not show an abnormal antistreptolysin titer. This is in sharp contrast to the high incidence of raised hemolytic streptococcus agglutinin titers observed in these patients even when the identical strain was used as an antigen to measure both antibodies.
7. Patients with other types of arthritis similarly failed to show an elevated antistreptolysin titer in a significant percentage of cases.
8. Because three-quarters of the patients with rheumatic polyarthritis showed an abnormally high titer and those with other forms of joint diseases did not, the test was found helpful in diagnosis. 9 . Patients with erythema nodosum of hemolytic streptococcal origin and patients with acute pericarditis of rheumatic type had, as a rule, an abnormal titer. When, however, these conditions were of a tuberculous origin, the titer was within normal limits. Here again the serological determination may be of diagnostic value. Further studies are needed to corroborate this impression since the number of cases here reported is small.
10. Several patients with lupus erythematosus disseminatus and periarteritis nodosa had a normal antistreptolysin titer.
11. In no disease have we found a correlation between the antistreptolysin titer and the severity of the illness; hence the titer is of doubtful prognostic significance.
12. Finally, it must be borne in mind that an elevated antistreptolysin titer may be found in a patient suffering with a disease not related to, but merely preceded by a hemolytic streptococcus in-fection. To reason that the elevated titer indicates that the presenting disease is of hemolytic streptococcal origin may lead to an erroneous diagnosis.
We wish to express our thanks to Mrs. Rose C. Alexander for her help in carrying out the various technical procedures.
